| 注册
首页|期刊导航|中国临床药理学杂志|阿帕替尼片治疗晚期胃癌的临床研究

阿帕替尼片治疗晚期胃癌的临床研究

文峰 向燕 王雷

中国临床药理学杂志2017,Vol.33Issue(7):589-591,3.
中国临床药理学杂志2017,Vol.33Issue(7):589-591,3.DOI:10.13699/j.cnki.1001-6821.2017.07.004

阿帕替尼片治疗晚期胃癌的临床研究

Clinical trial of apatinib tablets in the treatment of advanced gastric cancer

文峰 1向燕 2王雷3

作者信息

  • 1. 成都医学院第一附属医院肿瘤科,成都635400
  • 2. 新都区中医院妇科,四川 新都635400
  • 3. 四川省人民医院呼吸内科,成都610072
  • 折叠

摘要

Abstract

Objective To study the clinical efficacy and safety of apatinib tablets combined with tegafur,gimeracil and oteracil potassium capsules(S-1) and oxaliplatin injections in the treatment of advanced gastric cancer.Methods A total of 90 patients with advanced gastric cancer were randomly divided into control group and treatment group with 45 cases per group.Control group was given 130 mg · m-2 oxaliplatin,intravenous infusion for 2 h in the first day + oral S-1 twice a day after breakfast and dinner for 14 days,the dosages were 40,50,60 mg per time for the patients with the surface area < 1.25 m2,1.25-1.5 m2,> 1.5 m2,respectively.Treatment group orally received apatinib 850 mg qd,0.5 h after meal,on the basis of control group.Two groups were treated for 4 cycles with 3 weeks per cycle.The clinical efficacy and adverse drug reactions were compared between two groups.Results After treatment,the total effective rates in treatment and control groups were 40.00% (18/45 cases) and 24.44% (11/45 cases),disease control rates in treatment and control groups were 77.78% (35/45 cases) and 64.44% (29/45 cases),the differences were statistically significant (P < 0.05).In the treatment and control groups,the incidences of nausea and vomiting were 13.33% and 11.11%;neutropenia were 11.11% and 8.89%;diarrhea were 2.22% and 2.22%;hand-foot syndrome were 4.44% and 4.44%;thrombocytopenia were 6.67% and 8.89%,without significant differenee(P >0.05).In the treatment and control groups,the incidences of fatigue were 2.22% and 11.11%;hypertension were 2.22% and 11.11%;proteinuria were 0 and 6.67%,the differences were statistically significant (P < 0.05).Conclusion Apatinib tablets combined with S-1 and oxaliplatin injections have a definitive clinical efficacy and safety in the treatment of advanced gastric cancer.

关键词

阿帕替尼片/替吉奥胶囊/奥沙利铂注射剂/晚期胃癌

Key words

apatinib tablet/tegafur, gimeracil and oteracil potassium capsule/oxaliplatin injection/advanced gastric cancer

分类

医药卫生

引用本文复制引用

文峰,向燕,王雷..阿帕替尼片治疗晚期胃癌的临床研究[J].中国临床药理学杂志,2017,33(7):589-591,3.

基金项目

四川省科技基金资助项目(120078) (120078)

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文